CatalystPit

IRDOpus Genetics, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $4.84 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$402.67M
RECENT INSIDER TRADES
  • 2026-10-02 · Foundation Fighting Blindness Retinal Degeneration Fund (Director) · SELL
  • 2026-09-11 · Magrath George (Chief Executive Officer) · OTHER
  • 2026-09-08 · Gallagher Cam (Director) · OTHER
  • 2026-09-08 · Gagnon Robert E. (Chief Financial Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders107
Shares held59,965,518
Value$240.98M
Percent of shares outstanding72.08%
As of quarter end2026-06-30
RECENT NEWS
  • Opus Genetics presents at Euretina 2026
  • Foundation fighting blindness fund sells $2.75m in Opus Genetics stock
  • Opus Genetics, Inc. · 8-K (7.01,9.01)
  • Opus Genetics, Inc. · 8-K (7.01,8.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS